EE04415B1 - Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod - Google Patents

Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Info

Publication number
EE04415B1
EE04415B1 EEP200100041A EEP200100041A EE04415B1 EE 04415 B1 EE04415 B1 EE 04415B1 EE P200100041 A EEP200100041 A EE P200100041A EE P200100041 A EEP200100041 A EE P200100041A EE 04415 B1 EE04415 B1 EE 04415B1
Authority
EE
Estonia
Prior art keywords
compound
preparation
coat
antifungic
inert core
Prior art date
Application number
EEP200100041A
Other languages
English (en)
Inventor
Picornell Darder Carlos
Original Assignee
Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04415(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa, Liberacion Controlada De Sustancias Activas, S.A. filed Critical Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Publication of EE200100041A publication Critical patent/EE200100041A/et
Publication of EE04415B1 publication Critical patent/EE04415B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
EEP200100041A 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod EE04415B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
EE200100041A EE200100041A (et) 2002-06-17
EE04415B1 true EE04415B1 (et) 2005-02-15

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100041A EE04415B1 (et) 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Country Status (31)

Country Link
US (1) US6737082B1 (et)
EP (1) EP1103252B1 (et)
JP (1) JP4190732B2 (et)
KR (1) KR100572135B1 (et)
AT (1) ATE234077T1 (et)
AU (1) AU750730B2 (et)
BG (1) BG65187B1 (et)
BR (1) BR9912300A (et)
CA (1) CA2337509C (et)
CZ (1) CZ291938B6 (et)
DE (1) DE69905905T2 (et)
DK (1) DK1103252T3 (et)
EE (1) EE04415B1 (et)
ES (2) ES2157731B1 (et)
HK (1) HK1037531A1 (et)
HR (1) HRP20010128B1 (et)
HU (1) HU228895B1 (et)
IL (1) IL140910A (et)
ME (1) MEP26708A (et)
MX (1) MXPA01000681A (et)
NO (1) NO320054B1 (et)
NZ (1) NZ509886A (et)
PL (1) PL194740B1 (et)
PT (1) PT1103252E (et)
RS (1) RS50063B (et)
RU (1) RU2209628C2 (et)
SK (1) SK283279B6 (et)
TR (1) TR200100177T2 (et)
UA (1) UA64009C2 (et)
WO (1) WO2000004881A1 (et)
ZA (1) ZA200101293B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1122456C (zh) * 1996-01-31 2003-10-01 南亚拉巴马医学科学基金会 含有天然的还原叶酸盐异构体的食品和维生素制品
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
SI1438961T2 (sl) * 2003-01-14 2014-12-31 Cimex Pharma Ag Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
BRPI0412734A (pt) * 2003-07-17 2006-09-26 Tibotec Pharm Ltd processo para preparação de partìculas que contêm um antiviral
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
JP5435946B2 (ja) 2005-08-22 2014-03-05 ジョンズ ホプキンス ユニバーシティ 疾患を処置するためのヘッジホッグ経路アンタゴニスト
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
RU2017141029A (ru) * 2015-05-25 2019-06-25 Сан Фармасьютикал Индастриз Лимитед Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
WO2019208801A1 (ja) * 2018-04-27 2019-10-31 凸版印刷株式会社 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
IL124935A (en) * 1996-05-20 2001-06-14 Janssen Pharmaceutica Nv Dissolvable fungicidal preparations contain itraconazole with improved bioavailability
PE68898A1 (es) * 1996-05-24 1998-11-10 Schering Corp Composiciones antihongo con biodisponibilidad mejorada
KR20000022294A (ko) * 1996-06-28 2000-04-25 둘락 노먼 씨. 트리아졸 항진균 화합물을 함유하는 경구 조성물
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
PT969821E (pt) * 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero

Also Published As

Publication number Publication date
HUP0103708A2 (hu) 2002-02-28
ES2194480T3 (es) 2003-11-16
YU3901A (sh) 2003-08-29
NZ509886A (en) 2002-09-27
HUP0103708A3 (en) 2002-07-29
JP2002521323A (ja) 2002-07-16
KR20010070990A (ko) 2001-07-28
NO320054B1 (no) 2005-10-17
BG65187B1 (bg) 2007-06-29
ATE234077T1 (de) 2003-03-15
ZA200101293B (en) 2001-08-21
HRP20010128B1 (en) 2003-12-31
PL194740B1 (pl) 2007-06-29
CA2337509A1 (en) 2000-02-03
NO20010289L (no) 2001-03-07
US6737082B1 (en) 2004-05-18
EP1103252B1 (en) 2003-03-12
ES2157731B1 (es) 2002-05-01
IL140910A (en) 2004-03-28
EE200100041A (et) 2002-06-17
PT1103252E (pt) 2003-07-31
DK1103252T3 (da) 2003-07-14
HRP20010128A2 (en) 2002-12-31
DE69905905D1 (de) 2003-04-17
BG105282A (en) 2001-11-30
RU2209628C2 (ru) 2003-08-10
DE69905905T2 (de) 2004-03-04
KR100572135B1 (ko) 2006-04-19
TR200100177T2 (tr) 2001-07-23
NO20010289D0 (no) 2001-01-17
AU4782199A (en) 2000-02-14
ES2157731A1 (es) 2001-08-16
SK283279B6 (sk) 2003-05-02
IL140910A0 (en) 2002-02-10
CZ291938B6 (cs) 2003-06-18
MEP26708A (en) 2010-06-10
MXPA01000681A (es) 2002-04-24
AU750730B2 (en) 2002-07-25
HK1037531A1 (en) 2002-02-15
EP1103252A1 (en) 2001-05-30
PL345625A1 (en) 2002-01-02
UA64009C2 (en) 2004-02-16
CZ2001175A3 (en) 2001-05-16
WO2000004881A1 (es) 2000-02-03
SK862001A3 (en) 2001-08-06
JP4190732B2 (ja) 2008-12-03
BR9912300A (pt) 2001-04-17
RS50063B (sr) 2009-01-22
HU228895B1 (en) 2013-06-28
CA2337509C (en) 2005-12-27

Similar Documents

Publication Publication Date Title
EE04415B1 (et) Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod
DE69935677D1 (de) Antibiotische hydrophile beschichtung
DE69431807T2 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
BR9915087A (pt) Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem
DK76892A (da) Genstand med friktionsnedsaettende overfladebelaegning samt fremgangsmaade til fremstilling af en saadan belagt genstand
EP0351760A3 (en) Feed additive for ruminants
CA2348398A1 (en) Water-soluble coating agents bearing initiator groups and coating process
RU2001104894A (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
DE69100670D1 (de) Eine Suspension hydratisierter Spheroide einer hydrophilen Lipidsubstanz enthaltendes wässriges kosmetisches bzw. dermopharmazeutisches Mittel.
BRPI0407116A (pt) Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo
HK1063017A1 (en) Microgranules based on active principle and methodfor making same
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
HUP0203310A2 (hu) Benzimidazolszármazékot tartalmazó stabil gyógyszerkészítmények és eljárás ezek előállítására
JPS60137017A (ja) レジスト塗布装置
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20140720